Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Imiquimod and Local Radiotherapy for Treatment of Mycosis Fungoides

Trial Status: active

This phase I/II trial tests the safety and side effects of imiquimod and radiation therapy and how well they work in treating patients with mycosis fungoides. Imiquimod is in a class of medications called immune response modifiers. It also activates immune cells to attack and eliminate cancer cells. Radiation therapy uses high energy x-rays, particles, or radioactive seeds to kill cancer cells and shrink tumors. Giving imiquimod and radiation therapy may improve local control of mycosis fungoides.